Altamira Therapeutics CYTOF
OTC CYTOF
$0.09 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Altamira Therapeutics Ltd. (CYTOF) Accumulated Expenses (2018 - 2023)

Updated

Altamira Therapeutics (CYTOF) posted Accumulated Expenses of $393,267 for Q4 2023, down 80.8% from $2.05 million a year earlier.

Analysis

Altamira Therapeutics Ltd. (CYTOF) Accumulated Expenses (2018 - 2023) Analysis & Trends

Since Q4 2018, Altamira Therapeutics has reported Accumulated Expenses for 8 quarters.

  • Annual Accumulated Expenses shows a five-year compound annual growth rate of -21.2% (FY2018 to FY2023).
  • In prior years, Altamira Therapeutics' Accumulated Expenses was $2.05 million in FY2022 (+80.5%), $1.14 million in FY2021 (-28.3%), $1.59 million in FY2020 (+17.1%) and $1.35 million in FY2019 (+4.4%).
  • The Q4 2023 figure stands as the lowest quarterly Accumulated Expenses in data going back to Q4 2018.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 413,632.35
Dec 31, 2022 2.14 Mn
Dec 31, 2021 1.15 Mn
Dec 31, 2020 1.63 Mn
Jun 30, 2020 1.23 Mn
Dec 31, 2019 1.38 Mn
Jun 30, 2019 968,172.84
Dec 31, 2018 1.31 Mn
API Access

Altamira Therapeutics Ltd. Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CYTOF&period=max&api_key=YOUR_API_KEY